Skip to main content
Premium Trial:

Request an Annual Quote

Retiring Gordon

Representative Bart Gordon (D–TN), who is the chair of the House Science and Technology Committee, says he will retire next year. ScienceInsider chats with him abut what's on his plate until then. Gordon's priority will be re-authorizing the COMPETES Act and possibly improving it. "One of the things we've been doing is inventorying all the current STEM education programs, and we're finding tens of millions of additional dollars being spent on programs that nobody knew about," Gordon says, adding that "we want to be sure that those programs are well-coordinated."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.